| Plotted Points Statistics |
| 11-KETOTESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 102% | 20% | 106% | 24% |
| >= Reporting Level | 18 | 90% | 25% | 93% | 15% |
| Total | 22 | 92% | 24% | 96% | 20% |
| Sample Statistics |
| 11-KETOTESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 22 | 88% | Spiked |
| Estimated Values | 2 | 8% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 8% | Spiked |
| Spiked | 26 | . | |
| False Negatives | 1 | 4% | 1 out of 25 |
| Not Spiked | 21 | . | |
| False Positives | 0 | 0% | 0 out of 21 |
| Plotted Points Statistics |
| 17-ALPHA-ESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 80% | 11% | 78% | 12% |
| >= Reporting Level | 18 | 83% | 12% | 83% | 8% |
| Total | 22 | 82% | 11% | 82% | 12% |
| Sample Statistics |
| 17-ALPHA-ESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 22 | 88% | Spiked |
| Estimated Values | 2 | 8% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 4% | Spiked |
| Spiked | 26 | . | |
| False Negatives | 2 | 8% | 2 out of 25 |
| Not Spiked | 21 | . | |
| False Positives | 0 | 0% | 0 out of 21 |
| Plotted Points Statistics |
| 17-ALPHA-ETHYNYLESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 71% | 6% | 69% | 9% |
| >= Reporting Level | 18 | 83% | 16% | 80% | 16% |
| Total | 21 | 81% | 15% | 78% | 15% |
| Sample Statistics |
| 17-ALPHA-ETHYNYLESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 21 | 81% | Spiked |
| Estimated Values | 2 | 8% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 12% | Spiked |
| Spiked | 27 | . | |
| False Negatives | 2 | 8% | 2 out of 26 |
| Not Spiked | 20 | . | |
| False Positives | 0 | 0% | 0 out of 20 |
| Plotted Points Statistics |
| 17-BETA-ESTRADIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 24 | 80% | 7% | 79% | 8% |
| Total | 24 | 80% | 7% | 79% | 8% |
| Sample Statistics |
| 17-BETA-ESTRADIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 24 | 92% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 27 | . | |
| False Negatives | 2 | 8% | 2 out of 26 |
| Not Spiked | 20 | . | |
| False Positives | 3 | 15% | 3 out of 20 |
| Plotted Points Statistics |
| 3-BETA-COPROSTANOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 21 | 67% | 22% | 71% | 13% |
| Total | 21 | 67% | 22% | 71% | 13% |
| Sample Statistics |
| 3-BETA-COPROSTANOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 21 | 84% | Spiked |
| Estimated Values | 2 | 8% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 26 | . | |
| False Negatives | 4 | 16% | 4 out of 25 |
| Not Spiked | 21 | . | |
| False Positives | 0 | 0% | 0 out of 21 |
| Plotted Points Statistics |
| 4,4BISPHENOL F |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 6 | 70% | 19% | 74% | 26% |
| Total | 6 | 70% | 19% | 74% | 26% |
| Sample Statistics |
| 4,4BISPHENOL F |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 6 | 100% | Spiked |
| Estimated Values | 6 | 100% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 6 | . | |
| False Negatives | 0 | 0% | 0 out of 6 |
| Not Spiked | 41 | . | |
| False Positives | 0 | 0% | 0 out of 40 |
| Plotted Points Statistics |
| 4-ANDROSTENE-3,17-DIONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 43% | . | 43% | 0% |
| >= Reporting Level | 11 | 56% | 13% | 57% | 9% |
| Total | 12 | 55% | 13% | 56% | 11% |
| Sample Statistics |
| 4-ANDROSTENE-3,17-DIONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 12 | 71% | Spiked |
| Estimated Values | 1 | 6% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 12% | Spiked |
| Spiked | 17 | . | |
| False Negatives | 3 | 18% | 3 out of 17 |
| Not Spiked | 30 | . | |
| False Positives | 0 | 0% | 0 out of 29 |
| Plotted Points Statistics |
| BISPHENOL A |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 27 | 73% | 12% | 72% | 11% |
| Total | 27 | 73% | 12% | 72% | 11% |
| Sample Statistics |
| BISPHENOL A |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 27 | 100% | Spiked |
| Estimated Values | 27 | 100% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 28 | . | |
| False Negatives | 0 | 0% | 0 out of 27 |
| Not Spiked | 19 | . | |
| False Positives | 0 | 0% | 0 out of 19 |
| Plotted Points Statistics |
| CHOLESTEROL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 27 | 76% | 20% | 81% | 16% |
| Total | 27 | 76% | 20% | 81% | 16% |
| Sample Statistics |
| CHOLESTEROL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 27 | 100% | Spiked |
| Estimated Values | 4 | 15% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 28 | . | |
| False Negatives | 0 | 0% | 0 out of 27 |
| Not Spiked | 19 | . | |
| False Positives | 0 | 0% | 0 out of 19 |
| Plotted Points Statistics |
| CIS-ANDROSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 28 | 55% | 6% | 56% | 5% |
| Total | 28 | 55% | 6% | 56% | 5% |
| Sample Statistics |
| CIS-ANDROSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 28 | 97% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 29 | . | |
| False Negatives | 1 | 3% | 1 out of 29 |
| Not Spiked | 18 | . | |
| False Positives | 0 | 0% | 0 out of 17 |
| Plotted Points Statistics |
| DIHYDROTESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 16 | 66% | 18% | 69% | 7% |
| Total | 16 | 66% | 18% | 69% | 7% |
| Sample Statistics |
| DIHYDROTESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 16 | 89% | Spiked |
| Estimated Values | 3 | 17% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 6% | Spiked |
| Spiked | 18 | . | |
| False Negatives | 1 | 6% | 1 out of 18 |
| Not Spiked | 29 | . | |
| False Positives | 0 | 0% | 0 out of 28 |
| Plotted Points Statistics |
| EPITESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 17 | 70% | 24% | 75% | 13% |
| Total | 17 | 70% | 24% | 75% | 13% |
| Sample Statistics |
| EPITESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 17 | 94% | Spiked |
| Estimated Values | 3 | 17% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 18 | . | |
| False Negatives | 1 | 6% | 1 out of 18 |
| Not Spiked | 29 | . | |
| False Positives | 0 | 0% | 0 out of 28 |
| Plotted Points Statistics |
| EQUILENIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 12 | 88% | 57% | 52% | 68% |
| Total | 12 | 88% | 57% | 52% | 68% |
| Sample Statistics |
| EQUILENIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 12 | 100% | Spiked |
| Estimated Values | 2 | 17% | Spiked |
| Deleted Values | 1 | 3% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 13 | . | |
| False Negatives | 0 | 0% | 0 out of 12 |
| Not Spiked | 19 | . | |
| False Positives | 5 | 26% | 5 out of 19 |
| Plotted Points Statistics |
| EQUILIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 26 | 47% | 16% | 51% | 16% |
| Total | 26 | 47% | 16% | 51% | 16% |
| Sample Statistics |
| EQUILIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 26 | 96% | Spiked |
| Estimated Values | 26 | 96% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 28 | . | |
| False Negatives | 1 | 4% | 1 out of 27 |
| Not Spiked | 19 | . | |
| False Positives | 0 | 0% | 0 out of 19 |
| Plotted Points Statistics |
| ESTRIOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 26 | 76% | 12% | 80% | 14% |
| Total | 26 | 76% | 12% | 80% | 14% |
| Sample Statistics |
| ESTRIOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 26 | 100% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 27 | . | |
| False Negatives | 0 | 0% | 0 out of 26 |
| Not Spiked | 20 | . | |
| False Positives | 0 | 0% | 0 out of 20 |
| Plotted Points Statistics |
| ESTRONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 28 | 66% | 9% | 64% | 9% |
| Total | 28 | 66% | 9% | 64% | 9% |
| Sample Statistics |
| ESTRONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 28 | 97% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 29 | . | |
| False Negatives | 1 | 3% | 1 out of 29 |
| Not Spiked | 18 | . | |
| False Positives | 0 | 0% | 0 out of 17 |
| Plotted Points Statistics |
| MESTRANOL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 32% | . | 32% | 0% |
| >= Reporting Level | 17 | 40% | 8% | 41% | 6% |
| Total | 18 | 40% | 8% | 40% | 7% |
| Sample Statistics |
| MESTRANOL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 18 | 69% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 4 | 15% | Spiked |
| Spiked | 27 | . | |
| False Negatives | 4 | 15% | 4 out of 26 |
| Not Spiked | 20 | . | |
| False Positives | 0 | 0% | 0 out of 20 |
| Plotted Points Statistics |
| NORETHINDRONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 80% | 7% | 79% | 8% |
| >= Reporting Level | 17 | 72% | 18% | 72% | 10% |
| Total | 21 | 74% | 17% | 74% | 8% |
| Sample Statistics |
| NORETHINDRONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 21 | 84% | Spiked |
| Estimated Values | 2 | 8% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 4% | Spiked |
| Spiked | 26 | . | |
| False Negatives | 3 | 12% | 3 out of 25 |
| Not Spiked | 21 | . | |
| False Positives | 0 | 0% | 0 out of 21 |
| Plotted Points Statistics |
| PROGESTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 26 | 38% | 11% | 37% | 9% |
| Total | 26 | 38% | 11% | 37% | 9% |
| Sample Statistics |
| PROGESTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 26 | 90% | Spiked |
| Estimated Values | 26 | 90% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 29 | . | |
| False Negatives | 3 | 10% | 3 out of 29 |
| Not Spiked | 18 | . | |
| False Positives | 0 | 0% | 0 out of 17 |
| Plotted Points Statistics |
| TESTOSTERONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 75% | 18% | 71% | 20% |
| >= Reporting Level | 12 | 70% | 18% | 71% | 18% |
| Total | 16 | 72% | 17% | 71% | 18% |
| Sample Statistics |
| TESTOSTERONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 16 | 62% | Spiked |
| Estimated Values | 1 | 4% | Spiked |
| Deleted Values | 1 | 2% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 8% | Spiked |
| Spiked | 27 | . | |
| False Negatives | 8 | 31% | 8 out of 26 |
| Not Spiked | 20 | . | |
| False Positives | 5 | 25% | 5 out of 20 |